15 July 2013
The influence of clinical donor factors on acute rejection among lung and kidney recipients from the same multi-organ donor
Gregory I. SnellABCDEF, Bronwyn J. LevveyABCDE, Miranda ParaskevaBDE, Takahiro OtoBCDE, Michael BaileyCD, Rowan WalkerBCDE, Glen P. WestallABCDEDOI: 10.12659/AOT.883977
Ann Transplant 2013; 18:358-367
Abstract
BACKGROUND: Acute (AR) and Chronic (CR) rejection cause considerable morbidity and mortality following transplantation. This study explores the associations of biopsy proven AR in lung (LTx) and kidney (KTx) transplants recipients from the one donor.
MATERIAL AND METHODS: Between 2001 and 2006, 136 multiorgan donors contributed 144 LTx and 261 matching KTx. Utilizing LTx records and the Australian and New Zealand Dialysis and Transplant Registry, this study analyses the incidence and associations of LTx and KTx AR.
RESULTS: AR was noted in 49% of LTx [median of 17 (11-347) days] and 29% of KTx [median of 22 (1-1044) days]. Following univariate and multivariate analyses: 1) LTx AR was not associated with PGD in either LTx or KTX, nor with AR in KTx recipients, but was associated with donor PaO2/FiO2 ratio, type of LTx, CMV bronchoalveolar lavage load and extent of HLA mismatching; 2) KTx AR was not associated with PGD, but was associated with AR in the paired kidney, HLA DR mismatching and HLA A matching.
CONCLUSIONS: AR in LTx and KTx recipients from the same donor are not associated. AR and PGD do not appear linked in either organ. KTx (and not LTx) AR was associated with CR-related graft loss.
Keywords: Lung Transplantation, Allograft rejection, renal transplantation, Primary Graft Dysfunction
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588